STOCK TITAN

DXP Enterprises (DXPE) director granted 648 shares, now holds 14,612

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MANNES JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.

DXP Enterprises Inc. director Joseph R. Mannes reported receiving a grant of 648 shares of DXP Common Stock, valued at $165.90 per share. After this award, he holds 14,612 shares directly. The grant is scheduled to fully vest one year from its July 1, 2026 grant date.

Positive

  • None.

Negative

  • None.
Insider MANNES JOSEPH R
Role null
Type Security Shares Price Value
Grant/Award DXP Common Stock 648 $165.90 $108K
Holdings After Transaction: DXP Common Stock — 14,612 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Share grant size 648 shares DXP Common Stock grant to director on July 8, 2026
Grant price per share $165.90 per share Recorded value for the 648-share award
Total shares after grant 14,612 shares Director’s direct holdings following the transaction
DXP Common Stock financial
"security_title: "DXP Common Stock""
Grant date financial
"Grant date July 1, 2026 - 648 shares"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vesting financial
"The term of the grant provide for full vesting one year from the date of grant."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did DXP Enterprises (DXPE) director Joseph R. Mannes report?

Director Joseph R. Mannes reported receiving a grant of 648 shares of DXP Common Stock. This was a compensation-related award, not an open-market purchase, and increases his directly held stake in the company.

At what price was the DXP Enterprises (DXPE) share grant to Joseph R. Mannes recorded?

The 648-share grant to Joseph R. Mannes was recorded at $165.90 per share. This value reflects the share price used for the award in the Form 4 and helps indicate the size of the compensation.

How many DXP Enterprises (DXPE) shares does Joseph R. Mannes hold after this Form 4 transaction?

Following the grant, Joseph R. Mannes directly holds 14,612 shares of DXP Common Stock. This total includes the newly awarded 648 shares and gives investors a view of his current reported equity position.

When do the newly granted DXP Enterprises (DXPE) shares to Joseph R. Mannes vest?

The 648-share grant to Joseph R. Mannes is set to fully vest one year from the July 1, 2026 grant date. This means he earns full rights to the shares after that one-year vesting period.

Was the DXP Enterprises (DXPE) transaction by Joseph R. Mannes a market buy or a compensation grant?

The transaction was a compensation-related grant or award, not an open-market purchase. The Form 4 classifies it under a grant or other acquisition code, indicating it was issued as part of his role rather than bought on the market.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MANNES JOSEPH R

(Last)(First)(Middle)
5301 HOLLISTER ST

(Street)
HOUSTON TEXAS 77040

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DXP ENTERPRISES INC [ DXPE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
DXP Common Stock07/08/2026A648(1)A$165.914,612D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The term of the grant provide for full vesting one year from the date of grant. [Grant date July 1, 2026 - 648 shares]
Remarks:
/s/ Joseph R Mannes07/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)